Dr. Regis Louis Renard, MD

Dr. Renard practices at UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences.

Dr. Renard's NPI, 1730385741, was assigned on June 26, 2007. Dr. Renard holds Arkansas license E-8195.

Dr. Renard's primary practice is UAMS Medical Center, at 4301 West Markham Street Mail Slot 612, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 686-5000.

Dr. Renard's primary practice is UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences. The medical group on file is UAMS - University of Arkansas for Medical Sciences. Dmand AI also links Dr. Renard to 2 more medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Renard practices, 2 sites in all. Vendor and product names are available with a free account.

Orthopaedic trauma is Dr. Renard's primary specialty in the NPI Registry, under taxonomy code 207XX0801X. Dmand AI has Dr. Renard's licenses on file in 4 states: Arkansas, California, New Jersey and New York.

CMS data shows 143 Medicare services from Dr. Renard across 5 procedure codes in 2024, for 139 Medicare patients. Medicare paid $7,480 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 139 Medicare patients who saw Dr. Renard in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Renard's median patient age at 52, with 44% women.

In 2024, Dr. Renard wrote 86 Medicare Part D claims for 30 patients. 99% of them were for generic drugs. CMS names the drug for 35 of them, across 3 drugs with 11 or more claims each, at $687 in total drug cost. In 2023, CMS named 18 claims across 1 drug.

Dr. Renard accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Renard, published from 2014 to 2019. Dr. Renard's most frequent co-authors are Charles Lowry Barnes, MD, Bryan Beutel and Daniel S. Horwitz, MD.

Dmand AI links Dr. Renard to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Phantom Limb and Bronchiolitis Obliterans Syndrome.

CMS Open Payments shows 133 general payments to Dr. Renard from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 55% of the total. Orthofix Medical, Inc. paid the most, $16,039.